Who
Dawn Rogers
Director
Company insider
Files Form 4 as: Director, DXC Technology; Executive Vice President, Pfizer.
In numbers
- Trades disclosed
- 87
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $1.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Jun 2018
- Last trade
- 4 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 6 Aug 2026 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —18,100 at $0.00 | filing |
| 13 Aug 2024filed 15 Aug 2024 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —12,300 at $0.00 | filing |
| 7 Aug 2023filed 9 Aug 2023 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —12,400 at $0.00 | filing |
| 29 Jul 2022filed 2 Aug 2022 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —6,300 at $0.00 | filing |
| 20 Aug 2021filed 24 Aug 2021 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —5,600 at $0.00 | filing |
| 15 Apr 2021filed 19 Apr 2021 | DXC DXC TechnologyPayments & Processors | SEC FORM 4 Code A | —2,800 at $0.00 | filing |
| 15 Jun 2020filed 16 Jun 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,00260 at $33.36 | filing |
| 29 May 2020filed 1 Jun 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,98652 at $38.19 | filing |
| 15 May 2020filed 19 May 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,00153 at $37.76 | filing |
| 30 Apr 2020filed 1 May 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,99552 at $38.36 | filing |
| 29 Apr 2020filed 1 May 2020 | PFE PfizerPharmaceuticals | SEC FORM 4 Sold | $496K13,000 at $38.13 | filing |
| 15 Apr 2020filed 16 Apr 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,01456 at $35.97 | filing |
| 8 Apr 2020filed 9 Apr 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $30K862 at $34.60 | filing |
| 31 Mar 2020filed 1 Apr 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,86057 at $32.64 | filing |
| 13 Mar 2020filed 16 Mar 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,158 at $32.71 | filing |
| 28 Feb 2020filed 3 Mar 2020 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,824 at $0.00 | filing |
| 28 Feb 2020filed 3 Mar 2020 | PFE PfizerPharmaceuticals | SEC FORM 4 Code M | $488K17,824 at $27.37 | filing |
| 28 Feb 2020filed 3 Mar 2020 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $101K3,014 at $33.42 | filing |
News
Pfizer's 25-Valent Pediatric Vaccine Shows Strong Phase 2 DataPFE · miragenews.com · 24 Oct 2026Pfizer announces layoffs at NC facilitiesPFE · wsoctv.com · 24 Oct 2026Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemPFE · fool.com · 24 Oct 2026
0 headlines in the last 90 days name Dawn Rogers; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.